ResMed founder Dr. Peter Farrell has received the Horatio Alger Award, recognizing his contributions to respiratory care and ...

ResMed Inc (RMD) reports robust financial performance with 11% revenue growth and unveils new product launches amidst ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $279.86, with a ...

Resmed (NYSE: RMD) shares ticked up before hours today on second-quarter results that came in ahead of the consensus forecast ...

ResMed’s latest result highlights improved profitability and continued resilience in sleep and respiratory care markets, ...

Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, Canada and ...

Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP ...

Neutral editorial coverage examining institutional commentary, healthcare sector context, and index association surrounding a respiratory medical technology provider within established United States ...

Resmed has beaten expectations with $2 billion in second-quarter revenue and says weight loss drugs are actually boosting ...

Bourse falls on Friday as a pullback in gold sends miners tumbling; reports Kevin Warhs tipped as next Fed boss weighs on $A; Nine acquires QMS for $850m; ResMed beats consensus. Follow live.

KUALA LUMPUR, Malaysia--Malaysia and Singapore are finalizing the "master plan" for a special economic zone that has already netted over $17 billion in investment. The Johor-Singapore Special Economic ...